Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-) deprenyl
Authors:
- J. DalloJDJ. Dallo
- T.T. YenTYT.T. Yen
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 45 (6) , 525-531
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Increased life expectancy resulting from addition of l-deprenyl to Madopar treatment in Parkinson's disease: A longterm studyJournal of Neural Transmission, 1985
- The facilitation of dopaminergic activity in the aged brain by (−)deprenyl. A proposal for a strategy to improve the quality of life in senescenceMechanisms of Ageing and Development, 1985
- Theories of biological agingExperimental Gerontology, 1985
- Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeysEuropean Journal of Pharmacology, 1984
- Deprenyl (selegiline): the history of its development and pharmacological actionActa Neurologica Scandinavica, 1983
- Monoamine Oxidase Inhibitors in Bipolar Endogenous DepressivesJournal of Clinical Psychopharmacology, 1981
- Reduced dopaminergic binding during aging in the rodent striatumBrain Research, 1980
- The possible mechanisms of action of (-)deprenyl in Parkinson's diseaseJournal of Neural Transmission, 1978
- Levodopa, Fertility, and LongevityScience, 1977
- Relative effects of androgen upon the mating behavior of male rats subjected to forebrain injury or castrationJournal of Experimental Zoology, 1944